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Supporting Online Material 
 
General Methods 
 
Unless stated otherwise, reactions were performed in flame-dried glassware under a nitrogen or an 
argon environment, using freshly distilled solvents. Acetonitrile used for LC/MS was HPLC grade, and all 
aqueous solutions were made from nanopure water. All other commercially obtained reagents were used as 
received. Thin-layer chromatography (TLC) was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm). Visualization of the developed chromatogram was performed by fluorescence quenching, 
cerium ammonium molybdate stain, or ninhydrin stain as necessary. ICN silica gel (particle size 0.032 - 
0.063 mm) was used for flash chromatography. Gel filtration chromatography (Sephadex LH-20, G-10 
and G-25 ultrafine) and ion exchange chromatography [Sephadex C-25 (Na+)] were used in order to 
achieve purification of the final products. 
1H NMR and proton decoupling spectra were recorded on Varian Mercury 300 (300 MHz) and 
Varian Mercury 600 (600 MHz) spectrometers and the 1H NMR spectra are reported in parts per million (δ) 
relative to the residual solvent peak. Data for 1H are reported as follows: chemical shift (δ ppm), 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant in Hz, and 
integration. 13C NMR spectra were obtained on a Varian Mercury 300 (75 MHz) spectrometer and are 
reported in parts per million (δ) relative to the residual solvent peak. IR spectra were recorded on a Perkin 
Elmer Paragon 1000 spectrometer and are reported in terms of frequency of absorption (cm-1). A JASCO P-
1010 was used to measure optical rotation. Mass spectra were obtained from the Protein/Peptide 
MicroAnalytical Laboratory and the Mass Spectrometry Facility at the California Institute of Technology.  
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Synthetic Methods 
 
Allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-
O-p-methoxybenzylidene-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (5), methyl 2,3-di-O-
benzoyl-4-O-tert-butyldimethylsilyl-α-D-glucopyranosyluronate trichloroacetimidate (6), allyl 2-
deoxy-2-trichloroacetamido-4,6-O-p-methoxybenzylidene-β-D-galactopyranoside (7), methyl (2,3-di-
O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 →  3)-4,6-O-p-
methoxybenzylidene-2-deoxy-2-trichloroacetamido-α-D-galactopyranoside trichloroacetimidate (8), 
allyl (methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 →  3)-4,6-O-p-methoxybenzylidene-2-
deoxy-2-trichloroacetamido-β-D-galactopyranoside (9) were synthesized as described previously 1. 
 
Allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 
3)-(4,6-O-p-methoxybenzylidene-2-deoxy-2-trichloroacetamido-β-D-galactopyranosyl)-(1 → 4)-
(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-O-p-methoxybenzylidene-2-deoxy-
2-trichloroacetamido-β-D-galactopyranoside (10). 8 (0.10 g, 0.088 mmol) and 9 (0.065 g, 0.074 mmol) 
were combined and azeotroped by co-evaporation with toluene (3x) and placed under high vacuum 
overnight to dry. The mixture was dissolved in CH2Cl2 (3.0 mL) and 4Å powdered molecular sieves added. 
The mixture was stirred for 1 h at rt and then cooled to –75 °C. Trimethylsilyl trifluoromethanesulfonate 
(0.5 N solution in CH2Cl2, 0.0033 g, 0.015 mmol, 30 µL) was cooled to –75 °C and added dropwise to the 
reaction mixture. After 10 min, the reaction mixture was warmed to –20 °C, stirred for 30 min and then 
quenched with TEA. The mixture was filtered and concentrated to afford a yellow oil. Purification of this 
oil by flash chromatography (30 → 40% EtOAc:hexanes containing 0.1% TEA) afforded 10 (59 mg, 44%) 
as a white solid. Rf 0.43 (60% EtOAc:hexanes). [α]D25 = +13.4 (c = 0.5, CH2Cl2); IR (thin film on NaCl):  υ 
= 3424, 2956, 2361, 1732, 1638, 1519, 1452, 1368, 1251, 1173, 1093, 1173, 1093, 1070, 1028; 1H NMR 
(600 MHz, CDCl3): δ = 7.88 – 7.80 (m, 8H, ArH), 7.49 – 7.45 (m, 4H, ArH), 7.38 – 7.28 (m, 8H, ArH), 
7.22 – 7.20 (m, 2H, ArH), 7.06 (d, J = 8.4 Hz, 2H, C6H4OMe), 6.93 (d, J = 8.4 Hz, 2H, C6H4OMe), 6.85 (d, 
J = 6.6 Hz, 1H, NH), 6.74 (d, J = 8.4 Hz, 2H, Ph), 6.66 (d, J = 7.2 Hz, 1H, NH), 5.87 – 5.81 (m, 1H, 
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OCH2CH=CH2), 5.58 (dd, J = 7.8, 7.8 Hz, 1H, H-3 GlcA), 5.49 (s, 1H, MeOPhCH), 5.44 (dd, J = 8.7, 8.7 
Hz, 1H, H-3 GlcA), 5.35 (m, 2H, H-2 GlcA, H-2 GlcA), 5.23 (d, J = 18.0 Hz, 1H, OCH2CH=CH2), 5.20 (s, 
1H, MeOPhCH), 5.15 (m, 2H, OCH2CH=CH2, H-1 GlcA), 5.11 (d, J = 7.8 Hz, 1H, H-1 GalNAc), 5.03 (d, 
J = 7.2 Hz, 1H, H-1GlcA), 5.00 (d, J = 8.4 Hz, 1H, H-1 GalNAc), 4.68 (dd, J = 3.6, 10.8 Hz, 1H, H-3 
GalNAc), 4.58 (dd, J = 9.0, 9.0 Hz, 1H, H-4 GlcA), 4.39 – 4.30 (m, 5H, OCH2CH=CH2, H-3 GalNAc, H-4 
GalNAc, H-4 GlcA, H-6 GalNAc), 4.14 (m, 2H, H-4 GalNAc, H-5 GlcA), 4.06 (m, 3H, OCH2CH=CH2, H-
5 GlcA, H-6 GalNAc), 3.83 (s, 3H, PhOCH3), 3.81 – 3.68 (m, 4H, H-2 GalNAc, H-2 GalNAc, H-6 
GalNAc, H-6 GalNAc), 3.80 (s, 3H, PhOCH3), 3.80 (s, 3H, CO2CH3), 3.79 (s, 3H, CO2CH3), 3.48 (s, 1H, 
H-5 GalNAc), 3.10 (s, 1H, H-5 GalNAc), 0.72 (s, 9H, (CH3)3CSi), -0.09 (s, 3H, CH3Si), -0.24 (s, 3H, 
CH3Si); 13C NMR (75 MHz, CDCl3):  δ = 168.8, 168.4, 165.7, 165.4, 165.2, 165.1, 162.2, 161.9, 160.0, 
159.8, 133.8, 133.4, 133.3, 133.1, 130.5, 130.4, 130.2, 130.1, 130.0, 129.9, 129.6, 129.5, 129.2, 129.1, 
128.6, 128.5, 128.4, 127.9, 127.8, 118.2, 113.7, 113.4, 100.8, 100.5, 100.4, 100.2, 98.6, 97.7, 77.4, 76.4, 
75.9, 75.8, 75.3, 75.0, 74.2, 74.1, 73.5, 73.4, 72.1, 71.9, 70.8, 70.6, 69.3, 68.4, 66.9, 55.7, 55.6, 54.8, 53.5, 
52.8, 25.7, 18.1, -4.1, -4.8. ESI MS: m/z: calcd for C83H89Cl6N2O29Si: 1819.4; found 1819.5 [M + H]+. 
 
Allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 
3)-(2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-
glucopyranosyluronate)-(1 → 3)-2-deoxy-2-acetamido-β-D-galactopyranoside (11). Allyl (methyl 2,3-
di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(4,6-O-p-
methoxybenzylidene-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-
glucopyranosyluronate)-(1 → 3)-4,6-O-p-methoxybenzylidene-2-deoxy-2-acetamido-β-D-
galactopyranoside was prepared using a procedure modified from Bélot and coworkers 2.  To a solution of 
10 (98 mg, 0.054 mmol) in benzene (1.7 mL) and N,N-dimethylacetamide (0.43 mL) were added 
tributylstannane (0.20 mL, 0.97 mmol) and 2,2’-azobisisobutyronitrile (5.2 mg). The reaction mixture was 
stirred at rt for 30 min and then heated at 80 °C.  After 5 h, it was cooled to rt, concentrated to afford a 
yellow-white solid, and purified by flash chromatography (80% → 100% EtOAc:hexanes) to yield the 
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product as a white solid (80 mg, 92%). Rf 0.69 (100% EtOAc). 1H NMR (300 MHz, CDCl3): δ = 7.95 – 
7.84 (m, 8H, ArH), 7.52 – 7.43 (m, 6H, ArH), 7.38 – 7.27 (m, 8H, ArH), 7.21 (d, J = 9.0 Hz, 2H, 
C6H4OMe), 6.86 (d, J = 8.7 Hz, 2H, C6H4OMe), 6.80 (d, J = 9.0 Hz, 2H, Ph C6H4OMe), 5.89 – 5.76 (m, 
1H, OCH2CH=CH2), 5.61 (dd, J = 7.2, 8.1 Hz, 1H, H-3 GlcA), 5.51 (s, 1H, MeOPhCH), 5.44 (dd, J = 8.7, 
9.0 Hz, 1H, H-3 GlcA), 5.42 (d, J = 6.6 Hz, 1H, NH), 5.31 (dd, J = 6.6, 7.2 Hz, 1H, H-2 GlcA), 5.28 (dd, J 
= 7.2, 8.7 Hz, 1H, H-2 GlcA), 5.20 (dd, J = 0.9, 17.3 Hz, 1H, OCH2CH=CH2), 5.18 (s, 1H, MeOPhCH), 
5.13 (d, J = 11.4 Hz, 1H, OCH2CH=CH2), 5.11 (d, J = 8.1 Hz, 1H, H-1 GlcA), 5.05 (d, J = 7.2 Hz, 1H, H-1 
GalNAc), 4.98 (d, J = 6.6 Hz, 1H, NH), 4.89 (d, J = 7.5 Hz, 1H, H-1 GalNAc), 4.86 (d, J = 9.0 Hz, 1H, H-
1GlcA), 4.75 (dd, J = 3.3, 10.8 Hz, 1H, H-3 GalNAc), 4.51 (dd, J = 8.1, 9.3 Hz, 1H, H-4 GlcA), 4.37 – 
4.25 (m, 5H, OCH2CH=CH2, H-3 GalNAc, H-4 GalNAc, H-4 GlcA, H-6 GalNAc), 4.16 (d, J = 9.3 Hz, 1H, 
H-5 GlcA), 4.06 – 3.98 (m, 4H, OCH2CH=CH2, H-4 GalNAc, H-5 GlcA, H-6 GalNAc), 3.77 – 3.73 (m, 
1H, H-6 GalNAc), 3.80 (s, 3H, PhOCH3), 3.79 (s, 3H, PhOCH3), 3.73 (s, 3H, CO2CH3), 3.70 (s, 3H, 
CO2CH3), 3.56 – 3.52 (m, 1H, H-6 GalNAc), 3.46 (s, 1H, H-5 GalNAc), 3.35 – 3.26 (m, 2H, H-2 GalNAc, 
H-2 GalNAc), 2.84 (s, 1H, H-5 GalNAc), 1.54 (s, 3H, HNC(O)CH3), 1.50 (s, 3H, HNC(O)CH3), 0.70 (s, 
9H, (CH3)3CSi), -0.10 (s, 3H, CH3Si), -0.25 (s, 3H, CH3Si). ESI MS: m/z: calcd for C83H94N2O29Si: 1645.5; 
found 1645.4 [M + Cl]-. 
 
Allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(4,6-O-p-
methoxybenzylidene-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-
glucopyranosyluronate)-(1 → 3)-4,6-O-p-methoxybenzylidene-2-deoxy-2-acetamido-β-D-
galactopyranoside (42 mg, 0.026 mmol) was dissolved in CH3CN (840 µL) and H2O (90 µL), and the 
reaction was covered with aluminum foil and stirred in the dark. 2,3-Dichloro-5,6-dicyano-1,4-
benzoquinone (24 mg, 0.10 mmol) was added and the reaction stirred for 2 h at rt. The reaction mixture 
was subjected to Sephadex LH-20 (50% CH2Cl2:MeOH) to afford 11 as a pale pink solid (34 mg, 93%). Rf 
0.2 (100% EtOAc). 1H NMR (300 MHz, CD3OD): δ = 7.85 – 7.76 (m, 8H, ArH), 7.47 – 7.42 (m, 4H, 
ArH), 7.36 – 7.27 (m, 8H, ArH), 5.79 – 5.66 (m, 1H, OCH2CH=CH2), 5.52 (dd, J = 8.4, 8.4 Hz, 1H, H-3 
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GlcA), 5.51 (dd, J = 8.4, 9.9 Hz, 1H, H-3 GlcA), 5.27 – 5.19 (m, 3H), 5.12 (dd, J = 1.6 Hz, 17.3 Hz, 1H, 
OCH2CH=CH2), 5.00 – 4.96 (m, 4H), 4.43 – 4.42 (m, 1H), 4.32 – 4.26 (m, 2H), 4.20 – 4.10 (m, 5H), 4.00 
(d, J = 2.4 Hz, 1H), 3.96 – 3.88 (m, 3H), 3.70 (s, 3H, CO2CH3), 3.69 (s, 3H, CO2CH3), 3.41 – 3.35 (m, 2H), 
3.17 – 3.10 (m, 3H), 3.04 – 3.00 (m, 1H), 1.20 (s, 3H, HNC(O)CH3), 1.18 (s, 3H, HNC(O)CH3), 0.66 (s, 
9H, (CH3)3CSi), -0.10 (s, 3H, CH3Si), -0.26 (s, 3H, CH3Si). ESI MS: m/z: calcd for C67H82N2NaO27Si: 
1397.5; found 1397.6 [M + Na]+. 
 
Allyl (sodium β-D-glucopyranosyluronate)-(1 → 3)-(4,6-di-O-sodium sulfonato-2-deoxy-2-
acetamido-β-D-galactopyranosyl)-(1 → 4)-(sodium β-D-glucopyranosyluronate)-(1 → 3)-4,6-di-O-
sodium sulfonato-2-deoxy-2-acetamido-β-D-galactopyranoside (1: CS-E). To a solution of 11 (23 mg, 
0.017 mmol) in DMF (600 µL) was added SO3•TMA (90 mg, 0.64 mmol). The reaction stirred at 50 °C for 
2 d, after which time additional SO3•TMA (50 mg, 0.36 mmol) was added, and the reaction continued at 50 
°C for 1 d. It was quenched with MeOH, concentrated to afford a yellow solid, and purified on Sephadex 
LH-20 (50% CH2Cl2:MeOH). The resulting crude product was purified by flash chromatography (6:2:1 
EtOAc:MeOH:H2O) to afford allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-
glucopyranosyluronate)-(1 → 3)-(4,6-di-O-sodium sulfonato-2-deoxy-2-acetamido-β-D-galactopyranosyl)-
(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-di-O-sodium sulfonato-2-
deoxy-2-acetamido-β-D-galactopyranoside as a white solid (24 mg, 84%). Rf 0.51 (6:2:1 
EtOAc:MeOH:H2O). 1H NMR (300 MHz, CD3OD): δ = 7.92 – 7.81 (m, 8H, ArH), 7.55 – 7.45 (m, 4H, 
ArH), 7.43 – 7.33 (m, 8H, ArH), 5.87 – 5.73 (m, 1H, OCH2CH=CH2), 5.67 (dd, J = 9.0, 9.0 Hz, 1H, H-3 
GlcA), 5.61 (dd, J = 9.3, 9.3 Hz, 1H, H-3 GlcA), 5.42 – 5.32 (m, 3H), 5.19 (dd, J = 1.6, 17.3 Hz, 1H, 
OCH2CH=CH2), 4.93 – 4.79 (m, 4H, H-4 GalNAc, H-4 GalNAc), 4.54 – 4.52 (m, 1H), 4.49 (dd, J = 9.0, 
9.6 Hz, 1H, H-4 GlcA), 4.40 – 4.33 (m, 5H), 4.28 – 4.22 (m, 3H), 4.18 (d, J = 9.3 Hz, 1H, H-5 GlcA), 4.08 
– 3.98 (m, 4H), 3.90 – 3.89 (m, 1H), 3.87 (s, 3H, CO2CH3), 3.86 – 3.85 (m, 2H), 3.83 (s, 3H, CO2CH3), 
1.20 (s, 3H, HNC(O)CH3), 1.18 (s, 3H, HNC(O)CH3), 0.73 (s, 9H, (CH3)3CSi), -0.03 (s, 3H, CH3Si), -0.19 
(s, 3H, CH3Si). ESI MS: m/z: calcd for C67H78N2Na3O39S4Si: 1759.3; found 1759.8 [M - Na]-. 
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 Allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(4,6-di-
O-sodium sulfonato-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-
glucopyranosyluronate)-(1 → 3)-4,6-di-O-sodium sulfonato-2-deoxy-2-acetamido-β-D-galactopyranoside 
(32 mg, 0.019 mmol) in a plastic centrifuge tube was dissolved in pyridine (585 µL) and THF (585 µL). 
The reaction was cooled to 0 °C and to this was added HF•pyridine (94 µL, 5.2 mmol). After stirring at 0 
°C for 1 h and at rt overnight, the reaction mixture was loaded onto a Sephadex LH-20 column (50% 
CH2Cl2:MeOH). The product was concentrated, taken up in H2O, and lyophilized to afford a white solid 
(45 mg, 91%) that was immediately used in the next reaction. Rf 0.36 (6:2:1 EtOAc:MeOH:H2O). ESI MS: 
m/z: calcd for C61H67N2O39S4: 1579.2; found 1579.4 [M - H]-. 
 
The alcohol was deprotected in a manner similar to a procedure from Lucas and coworkers 3.  The alcohol 
(45 mg, 0.028 mmol) was dissolved in THF (2.3 mL) and H2O (1.7 mL) and cooled to 0 °C. To this were 
added 1 M aq. LiOH (330 µL) and 30% H2O2 (170 µL, 0.0015 mmol). The reaction stirred at 0 °C for 1 h 
and at rt for 12 h. At this time, 4 M NaOH (230 µL) and MeOH (1.7 mL) were added and the reaction 
stirred for another 12 h. It was then neutralized with Amberlyst IR-120 resin, filtered, and lyophilized to 
afford an orange solid. The product was purified by Sephadex G-25 UF (0.9 % NaCl in H2O) and desalted 
with Sephadex G-25 UF (100% H2O) to afford 1: CS-E as a white solid upon lyophilization (23 mg, 70%). 
1H NMR (600 MHz, D2O): δ = 5.94 – 5.88 (m, 1H, OCH2CH=CH2), 5.33 (dd, J = 1.5, 17.1 Hz, 1H, 
OCH2CH=CH2), 5.27 (d, J = 10.2 Hz, 1H, OCH2CH=CH2), 4.85 (s, 1H, H-4 GalNAc), 4.79 (d, J = 1.2 Hz, 
1H, H-4 GalNAc), 4.61 (dd, J = 3.9, 7.8 Hz, 1H, H-1 GalNAc), 4.59 (d, J = 7.8 Hz, 1H, H-1 GalNAc), 4.49 
(d, J = 7.8 Hz, 1H, H-1 GlcA), 4.47 (d, J = 7.8 Hz, 1H, H-1 GlcA), 4.35 (dd, J = 5.4, 13.2 Hz, 1H, 
OCH2CH=CH2), 4.29 (dd, J = 3.0, 11.4 Hz, 2H, H-6 GalNAc), 4.24 – 4.18 (m, 4H, OCH2CH=CH2, H-2 
GalNAc, H-5 GalNAc), 4.13 (dd, J = 2.7, 8.7 Hz, 1H, H-3 GalNAc), 4.09 – 4.05 (m, 4H, H-6 GalNAc, H-2 
GalNAc, H-3 GalNAc), 3.77 (dd, J = 9.6, 9.6 Hz, 1H, H-4 GlcA), 3.69 (d, J = 9.6 Hz, 1H, H-5 GlcA), 3.67 
(d, J = 9.6 Hz, 1H, H-5 GlcA), 3.61 (dd, J = 9.0, 9.6 Hz, 1H, H-3 GlcA), 3.52 (dd, J = 9.0, 9.0 Hz, 1H, H-4 
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GlcA), 3.47 (dd, J = 9.0, 9.6 Hz, 1H, H-3 GlcA), 3.41 (dd, J = 8.4, 9.0 Hz, 1H, H-2 GlcA), 3.34 (dd, J = 
7.8, 9.0 Hz, 1H, H-2 GlcA), 2.04 (s, 3H, HNC(O)CH3), 2.01 (s, 3H, HNC(O)CH3). ESI MS: m/z: calcd for 
C31H42N2Na5O35S4: 1245.0; found 1245.0 [M - Na]-. 
 
Allyl (β-D-glucopyranosyluronate)-(1 → 3)-(6-O-sulfonato-2-deoxy-2-acetamido-β-D-
galactopyranosyl)-(1 → 4)-(β-D-glucopyranosyluronate)-(1 → 3)-6-O-sulfonato-2-deoxy-2-acetamido-
β-D-galactopyranoside (2: CS-C). To a solution of 11 (25 mg, 0.018 mmol) in DMF (1.0 mL) was added 
SO3•TMA (17 mg, 0.12 mmol).  The reaction was stirred at 50 °C for 3 h, then cooled to rt, and eluted 
through a Sephadex LH-20 column (50% CH2Cl2:MeOH). The resulting crude product was purified by 
flash chromatography (6:1:1 EtOAc:MeOH:H2O) to afford allyl (methyl 2,3-di-O-benzoyl-4-O-tert-
butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(6-O-sulfonato-2-deoxy-2-acetamido-β-D-
galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-6-O-sulfonato-
2-deoxy-2-acetamido-β-D-galactopyranoside as a white solid (17 mg, 61%). Rf 0.32 (6:1:1 
EtOAc:MeOH:H2O). Also observed was allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-
glucopyranosyluronate)-(1 → 3)-(6-O-sulfonato-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-
(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-di-O-sulfonato-2-deoxy-2-acetamido-
β-D-galactopyranoside (8.6 mg, 31%) which could be used to generate 1: CS-E upon further sulfation. Rf 
0.16 (6:1:1 EtOAc:MeOH:H2O). Desired product 1H NMR (600 MHz, CD3OD): δ = 7.88 (dd, J = 6.0, 6.6 
Hz, 4H, ArH), 7.82 (dd, J = 6.6, 7.2 Hz, 4H, ArH), 7.53 – 7.49 (m, 4H, ArH), 7.40 – 7.33 (m, 8H, ArH), 
5.80 – 5.73 (m, 1H, OCH2CH=CH2), 5.60 (dd, J = 8.4, 9.0 Hz, 1H, H-3 GlcA), 5.56 (dd, J = 9.0, 9.6 Hz, 
1H, H-3 GlcA), 5.27 (dd, J = 8.4, 8.4 Hz, 2H, H-2 GlcA), 5.16 (d, J = 16.8 Hz, 1H, OCH2CH=CH2), 5.04 – 
5.00 (m, 3H), 4.48 (d, J = 7.8 Hz, 1H, H-1 GalNAc), 4.32 – 4.29 (m, 2H, H-1 GlcA, H-1 GalNAc), 4.25 – 
4.20 (m, 3H), 4.17 – 4.08 (m, 5H), 3.98  – 3.95 (m, 3H), 3.84 – 3.72 (m, 9H, CO2CH3), 3.69 – 3.60 (m, 
2H), 3.52 (dd, J = 5.4, 6.0 Hz, 1H), 1.19 (s, 6H, HNC(O)CH3), 0.70 (s, 9H, (CH3)3CSi), -0.05 (s, 3H, 
CH3Si), -0.21 (s, 3H, CH3Si). ESI MS: m/z: calcd for C67H81N2O33S2Si: 1533.4; found 1533.6 [M - H]-. 
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Allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(6-O-
sulfonato-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-
glucopyranosyluronate)-(1 → 3)-6-O-sulfonato-2-deoxy-2-acetamido-β-D-galactopyranoside (4.6 mg, 
0.0030 mmol) in a plastic centrifuge tube was dissolved in pyridine (55 µL) and THF (55 µL). The reaction 
was cooled to 0 °C and to this was added HF•pyridine (15 µL, 0.83 mmol). After stirring at 0 °C for 1 h 
and at rt overnight, the reaction mixture was loaded onto a Sephadex LH-20 column (50% CH2Cl2:MeOH). 
The product was concentrated, dissolved in H2O, and lyophilized to afford a white solid (3.8 mg, 89%) that 
was immediately used in the next reaction. Rf 0.44 (6:2:1 EtOAc:MeOH:H2O). ESI MS: m/z: calcd for 
C61H67N2O33S2: 1419.3; found 1419.6 [M - H]-. 
 
The alcohol (1.2 mg, 0.00084 mmol) was dissolved in THF (70 µL) and H2O (50 µL) and cooled to 0 °C. 
To this were added 1 M aq. LiOH (10.0 µL) and 30% H2O2 (5.0 µL, 0.044 µmol). The reaction was stirred 
at 0 °C for 1 h and at rt for 12 h. At this time, 4 M NaOH (7.0 µL) and MeOH (50 µL) were added and the 
reaction stirred for another 12 h. It was then neutralized with Amberlyst IR-120 resin, filtered, and 
lyophilized to afford an orange solid. The product was purified by Sephadex G-25 UF (0.9 % NaCl in H2O) 
and desalted with Sephadex G-25 UF (100% H2O) to afford 2: CS-C as a white solid upon lyophilization 
(0.8 mg, 100%). 1H NMR (600 MHz, D2O): δ = 5.93 – 5.86 (m, 1H, OCH2CH=CH2), 5.31 (d, J = 17.4 Hz, 
1H, OCH2CH=CH2), 5.26 (d, J = 10.8 Hz, 1H, OCH2CH=CH2), 4.53 (d, J = 8.4 Hz, 2H, H-1 GalNAc), 
4.50 (d, J = 7.2 Hz, 1H, H-1 GlcA), 4.49 (d, J = 7.2 Hz, 1H, H-1 GlcA), 4.34 (dd, J = 5.1, 13.5 Hz, 1H, 
OCH2CH=CH2), 4.23 – 4.16 (m, 7H, OCH2CH=CH2, H-4 GalNAc, H-6 GalNAc), 4.04 – 4.00 (m, 2H, H-2 
GalNAc), 3.99 (dd, J = 6.0, 6.0 Hz, 1H, H-5 GalNAc), 3.92 – 3.90 (m, 1H, H-5 GalNAc), 3.83 (d, J = 11.4 
Hz, 2H, H-3 GalNAc), 3.72 – 3.67 (m, 3H, H-4 GlcA, H-5 GlcA), 3.58 (dd, J = 8.4, 9.0 Hz, 1H, H-3 
GlcA), 3.49 (dd, J = 8.4, 9.0 Hz, 2H, H-3 GlcA, H-4 GlcA), 3.38 (dd, J = 8.4, 9.0 Hz, 1H, H-2 GlcA), 3.31 
(dd, J = 8.4, 8.4 Hz, 1H, H-2 GlcA), 2.02 (s, 3H, HNC(O)CH3), 2.00 (s, 3H, HNC(O)CH3). ESI MS: m/z: 
calcd for C31H46N2NaO29S2: 997.2; found 997.2 [M + Na - 2H]-. 
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Allyl (β-D-glucopyranosyluronate)-(1 → 3)-(4-O-sulfonato-2-deoxy-2-acetamido-β-D-
galactopyranosyl)-(1 → 4)-(β-D-glucopyranosyluronate)-(1 → 3)-4-O-sulfonato-2-deoxy-2-acetamido-
β-D-galactopyranoside (3: CS-A). 11 (60 mg, 0.44 mmol) was dissolved in pyridine (3.0 mL) and to this 
were added benzoyl cyanide (29 mg, 0.22 mmol) and 4-(dimethylamino)pyridine (13 mg, 0.11 mmol). The 
reaction stirred at rt for 12 h and was then concentrated to afford a yellow solid. The resulting crude 
product was purified by flash chromatography (100% EtOAc) to afford allyl (methyl 2,3-di-O-benzoyl-4-
O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(6-O-benzoyl-2-deoxy-2-acetamido-β-D-
galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-6-O-benzoyl-2-
deoxy-2-acetamido-β-D-galactopyranoside (64 mg, 93%). Rf 0.86 (100% EtOAc). 1H NMR (300 MHz, 
CDCl3): δ = 8.02 – 7.98 (m, 3H, ArH), 7.95 – 7.86 (m, 5H, ArH), 7.58 – 7.30 (m, 22H, ArH), 5.86 – 5.70 
(m, 1H, OCH2CH=CH2), 5.55 (dd, J = 9.0, 9.0 Hz, 2H, H-3 GlcA), 5.47 (d, J = 6.9 Hz, 1H, NH), 5.40 (dd, 
J = 8.4, 8.4 Hz, 2H, H-2 GlcA, NH), 5.32 (dd, J = 8.4, 8.7 Hz, 1H, H-2 GlcA), 5.15 (dd, J = 1.4, 17.3 Hz, 
1H, OCH2CH=CH2), 5.08 (dd, J = 1.4, 10.4 Hz, 1H, OCH2CH=CH2), 5.02 (d, J = 8.1 Hz, 1H, H-1 
GalNAc), 4.94 (d, J = 8.4 Hz, 1H, H-1 GalNAc), 4.88 (d, J = 7.5 Hz, 1H, H-1 GlcA), 4.83 (d, J = 7.8 Hz, 
1H, H-1 GlcA), 4.68 (dd, J = 3.2, 10.7 Hz, 1H, H-3 GalNAc), 4.61 (dd, J = 3.2, 10.7 Hz, 1H, H-3 GalNAc), 
4.56 – 4.54 (m, 2H), 4.30 – 4.23 (m, 3H), 4.11 – 4.01 (m, 5H), 3.92  – 3.84 (m, 2H), 3.68 – 3.59 (m, 8H, 
CO2CH3), 3.20 – 3.12 (m, 1H, H-5 GalNAc), 3.06 – 2.97 (m, 1H, H-5 GalNAc), 1.33 (s, 3H, HNC(O)CH3), 
1.33 (s, 3H, HNC(O)CH3), 0.70 (s, 9H, (CH3)3CSi), -0.07 (s, 3H, CH3Si), -0.21 (s, 3H, CH3Si). ESI MS: 
m/z: calcd for C81H91N2O29Si: 1583.6; found 1583.2 [M + H]+. 
 
Allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(6-O-
benzoyl-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-
glucopyranosyluronate)-(1 → 3)-6-O-benzoyl-2-deoxy-2-acetamido-β-D-galactopyranoside (64 mg, 0.040 
mmol) was dissolved in DMF (3.2 mL) and to this was added SO3•TMA (170 mg, 1.2 mmol). The reaction 
mixture was stirred at 50 °C for 2 d, then cooled to rt, and loaded onto a Sephadex LH-20 column (50% 
CH2Cl2:MeOH). The resulting crude product was purified by flash chromatography (6:0.5:0.5 
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EtOAc:MeOH:H2O) to afford allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-
glucopyranosyluronate)-(1 → 3)-(4-O-sulfonato-6-O-benzoyl-2-deoxy-2-acetamido-β-D-galactopyranosyl)-
(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-4-O-sulfonato-6-O-benzoyl-2-
deoxy-2-acetamido-β-D-galactopyranoside as a white solid (59 mg, 84%). Rf 0.40 (6:0.5:0.5 
EtOAc:MeOH:H2O). 1H NMR (300 MHz, CD3OD): δ = 8.06 (d, J = 7.5 Hz, 2H, ArH), 7.99 (d, J = 7.5 Hz, 
2H, ArH), 7.96 – 7.92 (m, 4H, ArH), 7.87 (d, J = 7.5 Hz, 2H, ArH), 7.80 (d, J = 7.5 Hz, 2H, ArH), 7.62 – 
7.32 (m, 16H, ArH), 7.26 (dd, J = 7.5, 7.5 Hz, 2H, ArH), 5.84 – 5.71 (m, 1H, OCH2CH=CH2), 5.55 (dd, J = 
9.0, 9.0 Hz, 1H, H-3 GlcA), 5.49 (dd, J = 9.0, 9.3 Hz, 1H, H-3 GlcA), 5.34 (dd, J = 7.8, 9.3 Hz, 1H, H-2 
GlcA), 5.29 (dd, J = 8.1, 8.1 Hz, 1H, H-2 GlcA), 5.16 – 5.14 (m, 3H), 5.06 (d, J = 13.5 Hz, 1H, 
OCH2CH=CH2), 4.98 (d, J = 10.2 Hz, 1H, OCH2CH=CH2), 4.93 (s, 1H, H-4 GalNAc), 4.78 (s, 1H, H-4 
GalNAc), 4.75 – 4.67 (m, 3H, H-1 GlcA, H-1 GalNAc) 4.51 (d, J = 7.8 Hz, 1H, H-1 GlcA), 4.43 (dd, J = 
9.0, 9.0 Hz, 1H, H-4 GlcA), 4.29 (dd, J = 7.5, 9.3 Hz, 1H), 4.21 – 4.10 (m, 4H), 4.02 – 3.89 (m, 5H), 3.74 – 
3.66 (m, 7H, CO2CH3), 3.47 (dd, J = 6.3, 6.3 Hz, 1H), 1.65 (s, 3H, HNC(O)CH3), 1.54 (s, 3H, 
HNC(O)CH3), 0.71 (s, 9H, (CH3)3CSi), -0.02 (s, 3H, CH3Si), -0.19 (s, 3H, CH3Si). ESI MS: m/z: calcd for 
C81H89N2O35S2Si: 1741.5; found 1742.0 [M - H]-. 
 
Allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(4-O-
sulfonato-6-O-benzoyl-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-
D-glucopyranosyluronate)-(1 → 3)-4-O-sulfonato-6-O-benzoyl-2-deoxy-2-acetamido-β-D-
galactopyranoside (59 mg, 0.034 mmol) in a plastic centrifuge tube was dissolved in pyridine (1.3 mL) and 
THF (1.3 mL). The reaction was cooled to 0 °C and to this was added HF•pyridine (210 µL, 11.6 mmol). 
After stirring at 0 °C for 1 h and at rt overnight, the reaction mixture was loaded onto a Sephadex LH-20 
column (50% CH2Cl2:MeOH). The product was concentrated, dissolved in H2O, and lyophilized to afford a 
white solid (50 mg, 90%) that was immediately used in the next reaction. Rf 0.46 (6:1:0.5 
EtOAc:MeOH:H2O). ESI MS: m/z: calcd for C75H75N2O35S2: 1627.4; found 1627.6 [M - H]-. 
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The alcohol (50 mg, 0.031 mmol) was dissolved in THF (3.3 mL) and H2O (2.5 mL) and cooled to 0 °C. To 
this were added 1 M aq. LiOH (370 µL) and 30% H2O2 (250 µL, 0.0022 mmol). The reaction stirred at 0 
°C for 1 h and at rt for 12 h. At this time, 4 M NaOH (330 µL) and MeOH (2.5 mL) were added and the 
reaction stirred for another 12 h. It was then neutralized with Amberlyst IR-120 resin, filtered, and 
lyophilized to afford an orange solid. The product was purified by Sephadex G-25 UF (0.9 % NaCl in H2O) 
and desalted with Sephadex G-25 UF (100% H2O) to afford 3: CS-A as a white solid upon lyophilization 
(21 mg, 70%). 1H NMR (600 MHz, D2O): δ = 5.94 – 5.86 (m, 1H, OCH2CH=CH2), 5.31 (dd, J = 1.5, 17.7 
Hz, 1H, OCH2CH=CH2), 5.27 (dd, J = 1.2, 10.2 Hz, 1H, OCH2CH=CH2), 4.79 (d, J = 3.0 Hz, 1H, H-4 
GalNAc), 4.74 (d, J = 3.0 Hz, 1H, H-4 GalNAc), 4.58 (d, J = 7.8 Hz, 1H, H-1 GalNAc), 4.56 (d, J = 7.8 
Hz, 1H, H-1 GalNAc), 4.47 (d, J = 7.8 Hz, 1H, H-1 GlcA), 4.46 (d, J = 7.8 Hz, 1H, H-1 GlcA), 4.34 (dd, J 
= 5.1, 13.5 Hz, 1H, OCH2CH=CH2), 4.18 (dd, J = 3.3, 13.2 Hz, 1H, OCH2CH=CH2), 4.07 – 4.00 (m, 4H, 
H-2 GalNAc, H-3 GalNAc), 3.85 – 3.77 (m, 7H, H-4 GlcA, H-6 GalNAc, H-5 GalNAc), 3.66 (d, J = 9.6 
Hz, 1H, H-5 GlcA), 3.66 (d, J = 10.2 Hz, 1H, H-5 GlcA), 3.58 (dd, J = 9.0, 9.0 Hz, 1H, H-3 GlcA), 3.52 
(dd, J = 9.0, 9.6 Hz, 1H, H-3 GlcA), 3.46 (dd, J = 9.0, 9.0 Hz, 1H, H-4 GlcA), 3.39 (dd, J = 8.4, 8.4 Hz, 
1H, H-2 GlcA), 3.34 (dd, J = 8.4, 8.4 Hz, 1H, H-2 GlcA), 2.04 (s, 3H, HNC(O)CH3), 2.01 (s, 3H, 
HNC(O)CH3). ESI MS: m/z: calcd for C31H46N2NaO29S2: 997.2; found 997.2 [M + Na - 2H]-. 
 
Allyl (2,3-di-O-sulfonato-β-D-glucopyranosyluronate)-(1 → 3)-(2-deoxy-2-acetamido-β-D-
galactopyranosyl)-(1 → 4)-(2,3-di-O-sulfonato-β-D-glucopyranosyluronate)-(1 → 3)-2-deoxy-2-
acetamido-β-D-galactopyranoside (4: CS-R). 11 (22 mg, 0.016 mmol) was dissolved in CH3CN (1.2 
mL), and to this were added benzaldehyde dimethyl acetal (120 µL, 0.78 mmol) and DL-10-
camphorsulfonic acid (3 mg).  The reaction was stirred at rt for 12 h, quenched with TEA, and concentrated 
to afford an orange solid.  The product was purified by flash chromatography (80% → 100% 
EtOAc:hexanes) to afford  allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-
glucopyranosyluronate)-(1 → 3)-(4,6-O-benzylidene-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-
(methyl 2,3-di-O-benzoyl-β-D-glucopyranosyluronate)-(1 → 3)-4,6-O-benzylidene-2-deoxy-2-acetamido-
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β-D-galactopyranoside (23 mg, 96%) as a white crystalline solid.  Rf 0.71 (100% EtOAc). 1H NMR (300 
MHz, CDCl3): δ = 7.94 – 7.85 (m, 4H, ArH), 7.86 (d, J = 8.1 Hz, 4H, ArH), 7.58 – 7.42 (m, 7H, ArH), 7.38 
– 7.27 (m, 15H, ArH), 5.89 – 5.76 (m, 1H, OCH2CH=CH2), 5.62 (dd, J = 7.8, 8.1 Hz, 1H, H-3 GlcA), 5.56 
(s, 1H, MeOPhCH), 5.49 (dd, J = 8.7, 8.7 Hz, 1H, H-3 GlcA), 5.43 (d, J = 6.9 Hz, 1H, NH), 5.34 – 5.23 (m, 
4H, H-2 GlcA, H-1 GalNAc, OCH2CH=CH2, MeOPhCH), 5.17 – 5.06 (m, 3H, H-2 GlcA, H-1 GalNAc, 
OCH2CH=CH2), 4.98 (d, J = 6.6 Hz, 1H, NH), 4.91 (d, J = 8.4 Hz, 1H, H-1 GlcA), 4.90 (d, J = 7.2 Hz, 1H, 
H-1GlcA), 4.77 (dd, J = 3.6, 11.1 Hz, 1H, H-3 GalNAc), 4.51 (dd, J = 8.4, 9.3 Hz, 1H, H-4 GlcA), 4.39 – 
4.28 (m, 5H, OCH2CH=CH2, H-3 GalNAc, H-4 GalNAc, H-4 GlcA, H-6 GalNAc), 4.16 (d, J = 9.6 Hz, 1H, 
H-5 GlcA), 4.07 – 3.99 (m, 4H, OCH2CH=CH2, H-5 GlcA, H-6 GalNAc), 3.79 – 3.70 (m, 7H, PhOCH3), 
3.57 (d, J = 11.4 Hz, 1H), 3.48 (s, 1H, H-5 GalNAc), 3.35 – 3.29 (m, 2H), 2.87 (s, 1H, H-5 GalNAc), 1.54 
(s, 3H, HNC(O)CH3), 1.51 (s, 3H, HNC(O)CH3), 0.70 (s, 9H, (CH3)3CSi), -0.11 (s, 3H, CH3Si), -0.25 (s, 
3H, CH3Si). ESI MS: m/z: calcd for C81H90N2NaO27Si: 1573.5; found 1573.6 [M + Na]+. 
 
Allyl (methyl 2,3-di-O-benzoyl-4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(4,6-O-
benzylidene-2-deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl 2,3-di-O-benzoyl-β-D-
glucopyranosyluronate)-(1 → 3)-4,6-O-benzylidene-2-deoxy-2-acetamido-β-D-galactopyranoside (23 mg, 
0.015 mmol) was dissolved in THF (2.0 mL) and H2O (1.0 mL) and cooled to 0 °C. To this were added 1 
M aq. LiOH (175 µL) and 30% H2O2 (120 µL, 1.1 µmol). The reaction was stirred at 0 °C for 1 h and at rt 
for 12 h. At this time, 4 M NaOH (1.5 mL) and MeOH (1.2 mL) were added and the reaction stirred for 
another 12 h. It was then neutralized with Amberlyst IR-120 resin, filtered, and lyophilized to afford an 
orange solid. The product was purified by flash chromatography (6:2:1 EtOAc:MeOH:H2O) to afford allyl 
(methyl 4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(4,6-O-benzylidene-2-deoxy-2-
acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl β-D-glucopyranosyluronate)-(1 → 3)-4,6-O-
benzylidene-2-deoxy-2-acetamido-β-D-galactopyranoside (9.3 mg, 56%). The yield was reduced due to 
partial migration of the tert-butyldimethylsilyl protecting group during the reaction. Rf 0.75 (6:2:1 
EtOAc:MeOH:H2O). 1H NMR (600 MHz, CD3OD): δ = 7.50 – 7.49 (m, 4H, ArH), 7.35 – 7.31 (m, 6H, 
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ArH), 5.92 – 5.86 (m, 1H, OCH2CH=CH2), 5.66 (s, 1H, MeOPhCH), 5.58 (s, 1H, MeOPhCH), 5.28 (d, J = 
17.4 Hz, 1H, OCH2CH=CH2), 5.14 (d, J = 11.4 Hz, 1H, OCH2CH=CH2), 4.66 (d, J = 8.4 Hz, 1H, H-1 
GalNAc), 4.58 (d, J = 7.8 Hz, 1H, H-1 GlcA), 4.52 (d, J = 8.4 Hz, 1H, H-1 GalNAc), 4.42 – 4.32 (m, 4H), 
4.27 – 4.22 (m, 1H), 4.17 – 4.07 (m, 5H), 3.88 – 3.84 (m, 2H), 3.70 (dd, J = 9.0, 9.6 Hz, 1H), 3.64 – 3.61 
(m, 3H), 3.53 – 3.52 (m, 3H), 3.45 (dd, J = 8.4, 9.0 Hz, 1H, H-3 GlcA), 3.43 (dd, J = 7.2, 9.0 Hz, 1H, H-3 
GlcA), 3.37 (dd, J = 9.0, 9.0 Hz, 1H, H-2 GlcA), 3.16 (dd, J = 7.8, 8.4 Hz, 1H, H-2 GlcA), 2.01 (s, 3H, 
HNC(O)CH3), 1.93 (s, 3H, HNC(O)CH3), 0.87 (s, 9H, (CH3)3CSi), 0.09 (s, 3H, CH3Si), 0.08 (s, 3H, 
CH3Si). ESI MS: m/z: calcd for C51H69N2O23Si: 1105.4; found 1105.6 [M - H]-. 
 
Allyl (methyl 4-O-tert-butyldimethylsilyl-β-D-glucopyranosyluronate)-(1 → 3)-(4,6-O-benzylidene-2-
deoxy-2-acetamido-β-D-galactopyranosyl)-(1 → 4)-(methyl β-D-glucopyranosyluronate)-(1 → 3)-4,6-O-
benzylidene-2-deoxy-2-acetamido-β-D-galactopyranoside (9.3 mg, 0.0084 mmol) was dissolved in DMF 
(500 µL) and to this was added SO3•TEA (30 mg, 0.17 mmol).  The reaction mixture was stirred at 65 °C 
for 36 h, then cooled to rt, and loaded onto a Sephadex LH-20 column (50% CH2Cl2:MeOH). The product 
was concentrated, dissolved in H2O, and lyophilized to afford a yellow solid (7.5 mg) that was immediately 
used in the next reaction. Prolonged reaction times or greater amounts of sulfating reagent led to 
degradation of the product during the reaction to afford a mixture of the desired product, various sulfated 
disaccharides, and loss of the tert-butyldimethylsilyl protecting group to afford the pentasulfated product. 
ESI MS: m/z: calcd for C57H83N3O35S4Si: 1526.6; found 1526.4 [M + TEA – 2H]-. 
 
The tetrasulfated product (7.5 mg, 0.053 mmol) was dissolved in 0.01 M AcOH, pH 3.0 (500 µL) and the 
reaction stirred at rt for 4 d. During this time, the pH was carefully monitored to prevent loss of the allyl 
group. The reaction was then quenched with TEA and concentrated to afford a yellow syrup. The product 
was purified by Sephadex G-25 UF (H2O) and Sephadex C-25 (Na+) (H2O) chromatography. 4: CS-R was 
afforded as a white solid upon lyophilization (1.6 mg, 17%, 2 steps). 1H NMR (600 MHz, D2O): δ = 5.90 – 
5.83 (m, 1H, OCH2CH=CH2), 5.28 (d, J = 17.4 Hz, 1H, OCH2CH=CH2), 5.22 (d, J = 10.8 Hz, 1H, 
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OCH2CH=CH2), 4.96 (d, J = 5.4 Hz, 1H, H-1 GlcA), 4.93 (d, J = 6.0 Hz, 1H, H-1 GlcA), 4.58 (d, J = 7.8 
Hz, 1H, H-1 GalNAc), 4.52 (d, J = 8.4 Hz, 1H, H-1 GalNAc), 4.45 – 4.44 (m, 2H, H-2 GlcA), 4.38 (dd, J = 
9.0, 9.0 Hz, 1H, H-4 GlcA), 4.30 (dd, J = 5.4, 13.2 Hz, 1H, OCH2CH=CH2), 4.18 – 4.10 (m, 4H, 
OCH2CH=CH2, H-4 GlcA, H-3 GlcA), 4.02 – 3.97 (m, 2H, H-2 GalNAc), 3.94 (dd, J = 8.7, 10.2 Hz, 2H, 
H-5 GlcA), 3.89 – 3.82 (m, 3H, H-3 GalNAc, H-4 GalNAc), 3.77 –3.73 (m, 3H, H-3 GalNAc, H-6 
GalNAc), 3.67 – 3.64 (m, 4H, H-5 GalNAc, H-6 GalNAc), 2.02 (s, 6H, HNC(O)CH3). ESI MS: m/z: calcd 
for C31H46N2O35S4: 567.0; found 567.0 [M – 2H]2-. In addition to the previously described conditions, CS-R 
could also be purified by liquid chromatography/mass spectrometry (LC/MS). Separations were performed 
on a Hewlett Packard (Agilent) 1100 LC-MSD with an Agilent Zorbax Stable Bond C18 column (80 Å 
pore, 4.6 x 250 mm). Eluent A was water/acetonitrile (80:20) and eluent B was water/acetonitrile (35:65). 
Tributylamine (15 mM) and ammonium acetate (50 mM) were added to both eluents. The mobile phase pH 
was adjusted to 7.0 with acetic acid 4. Sample injection sizes were 40 µL, and a linear gradient (from 0 to 
100% eluent B in 120 min) at a flow rate of 0.5 mL/min was used for elution. ESI mass spectra were 
obtained with the electrospray interface set in negative ionization mode with a fragmentor voltage of 60 V, 
a capillary voltage of –3500 V, and a source temperature of 350 °C. Nitrogen was used as a drying (12 
L/min) and nebulizing gas (60 p.s.i.). Total ion chromatograms and mass spectra were processed using 
Agilent Chemstation. Optimization of the method was performed with pure CS-A (22 min), CS-E (34 min), 
and mixtures of CS-A and CS-E tetrasaccharides. CS-R eluted at 28 min. 
 
Conjugation of CS Oligosaccharides to 1,2-(Bisaminooxy)ethane for Microarray Production 
Ozonolysis of the anomeric allyl group and linkage of CS compounds 1-4 to 1,2-
(bisaminooxy)ethane5 proceeded as follows: oligosaccharide (0.51 µmol) was dissolved in MeOH (500 µL) 
and cooled to –78 °C. O3 was bubbled through the reaction until a blue color persisted (1 min). The reaction 
was then purged with N2 until colorless, quenched with Ph3P beads (3 mg), and gradually warmed to rt over 
12 h. It was filtered and the product concentrated to afford the desired aldehyde as a white solid. The 
aldehyde (0.51 µmol) was then reacted for 14 h at rt with 1,2-(bisaminooxy)ethane hydrochloride (1.4 mg, 
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15 µmol) that had been dissolved in H2O (100 µL) and pH adjusted to 5.0 with 1 M NaOH. The resulting 
oxime product was purified using a SepPak C18 column (500 mg, H2O) and Sephadex G-10 (CS-E 
disaccharide, H2O) or Sephadex G-25 (tetrasaccharides, H2O) to afford a white solid in quantitative yield 
(0.51 µmol). CS-A aminooxy: ESI MS: m/z: calcd for C32H48N4Na3O31S2: 1117.1; found 1117.0. CS-C 
aminooxy: ESI MS: m/z: calcd for C32H48N4Na3O31S2: 1117.1; found 1117.0. CS-E aminooxy: ESI MS: 
m/z: calcd for C32H46N4Na5O37S4: 1321.0; found 1321.0. CS-R amminooxy: ESI MS: m/z: calcd for 
C32H46N4Na5O37S4: 1321.0; found 1321.0. 
 The relative concentrations of the aminooxy oligosaccharides were calibrated to one another using 
the carbazole assay for uronic acid residues6. Briefly, the acid borate reagent (1.5 mL of 0.80 g sodium 
tetraborate, 16.6 mL H2O, and 83.3 mL H2SO4) was added to 20-mL glass vials with Teflon caps. The 
aminooxy oligosaccharides (50 µL of a 0.2 mg/mL stock in H2O) were added and the solution placed in a 
boiling H2O bath for 10 min. Following addition of the carbazole reagent (50 µL of 0.1% w/v carbazole in 
100% EtOH), the solution was boiled for 15 min. The absorbance was read at 530 nm and compared to a D-
glucuronolactone standard in H2O. 
 
CS-C Antibody Development 
The CS-C monoclonal antibody was generated according to standard immunological techniques, 
using the CS-C tetrasaccharide conjugated to keyhole limpet hemocyanin (KLH) as the antigen.  The 
conjugation of tetrasaccharide 2 to KLH was performed as follows.  Ozonolysis of the anomeric allyl group 
of the tetrasaccharide (0.51 µmol) as described above was followed by treatment with KLH (0.44 mg, 
0.0063 µmol) and NaCNBH3 (0.5 mg) in H2O (pH’d with 5% K2CO3 to pH 9.5) for 2 d at rt. The product 
was then exhaustively dialyzed against 0.01 M Na2HPO4, 0.15 M NaCl, pH 7.4 at 4 °C and the protein 
concentration determined by BCA assay (Pierce). The epitope density was determined by comparing the 
conjugated proteins to the unconjugated proteins using the Habeeb assay7. In short, to the protein solution 
(10 µL) in PBS (40 µL) were added 0.1% trinitrobenzenesulfonic acid (50 µL) and 4% NaHCO3, pH 9.5 
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(50 µL).  The mixture was incubated at 40 °C for 2 h, quenched with 10% SDS (50 µL), 1 M HCl (25 µL), 
and H2O (500 µL), and the absorbance at 363 nm was measured to afford an epitope density of 15. 
Three Balb/c female mice, 4-6 weeks old, were primed and boosted at 2-week intervals for a total of 
5 intraperitoneal injections (5 µg per injection).  The CS-C-KLH conjugate was mixed with RIBI adjuvant 
(RIBI Immunochem) for the first two injections, and a final series of 3 boosts was performed without 
adjuvant.  Bleeds were taken 1 week after each injection and monitored by dot blot analysis.  The most 
responsive mouse was boosted and sacrificed after three days.  Spleen cells were fused with HL-1 murine 
myeloma cells (Ventrex) using polyethylene glycol (PEG 1500, Boehringer-Mannheim) as described 
previously by Lebron et al.8  Multiclonal and monoclonal cell lines were screened via ELISA and dot blot 
analysis. 
 
ELISA Analysis 
CS tetrasaccharides 1-3 were conjugated to bovine serum albumin (BSA) as follows. Ozonolysis 
of the anomeric allyl group of the CS-A, -C, and -E tetrasaccharides (0.51 µmol) as described above was 
followed by treatment of each compound with BSA (0.34 mg, 0.0051 µmol) and NaCNBH3 (0.5 mg) in 
H2O (pH 9.5 using K2CO3) for 2 d at rt. The CS-BSA conjugates were then exhaustively dialyzed against 
0.01 M Na2HPO4, 0.15 M NaCl, pH 7.4 at 4 °C, and the protein concentrations were determined using the 
BCA assay (Pierce). The epitope densities were measured by comparing the conjugated proteins to the 
unconjugated proteins using the Habeeb assay. The epitope densities were as follows: CS-A conjugate = 
14, CS-C conjugate = 16, CS-E conjugate = 14. 
The BSA conjugates (1 µg/mL in 50 mM Na2CO3, pH 9.6) were added to a 384-well NUNC 
Maxisorp clear plate (25 µL per well), and the plate was sealed and incubated for 12 h at 4 °C. The wells 
were aspirated, washed four times with PBS containing 0.05% Tween-20 (PBST, 75 µL/wash), and 
blocked for 2 h at rt with 10% horse serum (Gibco) in PBS (75 µL). After the blocking step, the plate was 
washed four times with PBST, and the supernatants from the CS-C antibody producing cultures (25 µL) 
were added to the wells and incubated at rt for 2 h. Following aspiration, the wells were washed four times 
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with PBST and treated with a horseradish peroxidase (HRP)-conjugated goat anti-mouse antibody (Pierce; 
1:10,000, 25 µL/well) in blocking buffer for 1 h at rt. The wells were again aspirated, washed four times 
with PBST, and then developed with ABTS liquid substrate solution (Sigma; 25 µL/well, solution at rt) for 
30 min at rt. Color development was monitored on a Victor plate reader (PerkinElmer) at 405 nm. Only 
clones specific for the CS-C tetrasaccharide and with absorbance values greater than 1.0 were kept for 
subsequent dot blot screening. 
 
Dot Blot Analysis 
Immunoblotting analysis was performed by spotting solutions of the BSA conjugates (relative 
epitope density adjusted, 1-100 ng, 1 µL/spot) in 10 mM Tris•HCl, 0.02% Nonidet P-40, pH 7.5 onto 0.45 
µm nitrocellulose, allowing the spots to air dry, and fixing the blots with 40% MeOH, 10% AcOH, 50% 
H2O for 15 min at rt. The dot blots were then blocked for 30 min in 5% non-fat milk containing 50 mM 
Tris•HCl pH 7.4, 150 mM NaCl, 0.05% Tween-20 (TBST) followed by treatment with appropriate 
dilutions (1:500, 1:1000, and 1:2000) of the antibody serum in blocking buffer or supernatant from the 
monoclonal cell cultures for 2 h at rt. The blots were then washed with TBST three times for 10 min and 
treated with an HRP-conjugated goat anti-mouse antibody (Pierce; 1:10,000) in blocking buffer for 1 h at 
rt. The dot blots were washed with TBST three times for 10 min and visualized by chemiluminescence 
(SuperSignal West Pico, Pierce).  
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